[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_column_text]Read the FY 2026 Results Summary: FY 2026 Results Summary View on the ASX here: Appendix 4E and Full...
Global Health Limited (ASX: GLH) is pleased to advise that its Global Health Limited Half Year 2026 Results Update for Investors has been lodged on the ASX...
Read the full Global Health Limited December 2025 Half Year Results Summary on the ASX website here. To view our Appendix 4D and Half Year Accounts please...
Read the FY 2025 Results Summary: FY 2025 Results Summary View on the ASX here: Appendix 4E and Full Year Statutory Accounts ...
Read the 2025 Appendix 4E and Full Year Statutory Accounts: 2025 Appendix 4E and Full Year Statutory Accounts View on the ASX here: Appendix 4E and...
Review of operations For the Half Year Ended 31 December 2024 The Group continued to engage in its principal activities being the development, sales and support...
Global Health achieves turnaround results in 2024 Global Health Limited (ASX:GLH) (“Global Health” or “the Group”) is pleased to release its 2024 Annual Report, announcing a...
Result highlights include: Revenue up 27% or $856K to $4.039M Expenses reduced by 12% or $0.69M to ($5.2M) EBITDA up 58% or $1.5M to ($1M) ...
Global Health is excited to present our Annual Report, showcasing our achievements in the past year. The highlights include: 20% increase in Customer Revenue to $7.81...
Global Health Limited is pleased to present our full year-2022 annual report and business update. Financial highlights A year of investment, following a capital raising, has delivered...